Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03998488 · ClinicalTrials.gov registry record · Phase 2
Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis
A Phase 2 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 2
- Development phase
- 27
- Enrollment target
NCT03998488 is a Phase 2 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 27 participants.
The verdict
NCT03998488, a Phase 2 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 27 participants
- Enrollment target
Study Summary
A double-blind, randomized, placebo-controlled clinical trial examining the efficacy and safety of Fecal Microbiota Transplantation (FMT) and high fiber supplementation in patients with active mild to moderate Ulcerative Colitis (UC). All enrolled subjects will provide serological, stool and mucosal specimen at each clinic visit to help further define the alterations in microbial profiles and immune cell function in response to psyllium fiber after FMT treatment.
Interventions
- DRUG Fecal Microbiota Transplantation
- DIETARY_SUPPLEMENT Psyllium Husk Powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2020-01-31 |
| Est. Completion | 2024-04-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03998488
The ClinicalTrials.gov registry entry for NCT03998488 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fecal Microbiota Transplantation is the first listed.
NCT03998488 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03998488 about?
NCT03998488 is a clinical study titled "Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis". A double-blind, randomized, placebo-controlled clinical trial examining the efficacy and safety of Fecal Microbiota Transplantation (FMT) and high fiber supplementation in patients with active mild to moderate Ulcerative Colitis (UC). All enrolled subjects will provide serological, stool and mucosal...
What is the current status of trial NCT03998488?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 27 participants. The study started on 2020-01-31. Estimated completion is 2024-04-12.
What interventions are being tested in trial NCT03998488?
The interventions under investigation include: Fecal Microbiota Transplantation (DRUG), Psyllium Husk Powder (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03998488?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.